Laddar populära aktier...
Luxbright har levererat en första leverans av ett kundspecifikt röntgenrör till Fisica Inc.
Redeye updates its estimates ahead of the Q2 report following today’s announced 5G order.
Redeye comments on EG7’s acquisition of S6 which is the developer and publisher of the online multip...
Redeye offers a preview of Advenica's Q2 results set to be released on July 19th.
Redeye provides an update as we resume our coverage after CLS’ rights issue.
Nettoomsättningen uppgick till 43,7 MSEK (44,4) i det fjärde kvartalet (februari-april) i Purefuns b...
Q2 likely similar to Q1 Q2 seems to have developed in a similar way to Q1, with the trend of longer ...
What to expect in Q2'24 We expect sales of SEK 266m for Q2'24, implying a y-o-y decline of -11%, alo...
Kinda Brave Entertainment Group AB (”Kinda Brave” eller ”Koncernen”) meddelade den 28 juni år 2024 a...
Redeye briefly comments on Navigo announcing several leadership changes.
Last week Railcare announced a deal that will secure the supply of locomotives for some of its impor...
Redeye comments on the published interim data from the MASCC/AFSOS/ISOO 2004 annual meeting in Lille...
The Danish Systemic Risk Council recommends that the Faroe systemic risk buffer is hiked to 3% (curr...
Redeye comments on Optomed’s directed share issue, raising approximately EUR7.
Redeye provides a brief comment on the selection of a new drug candidate.
